Effect of epidural spinal cord stimulation on female sexual function after spinal cord injury.

neuromodulation orgasm sexual arousal sexual dysfunction sexual health sexuality spinal cord injuries

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2023
Historique:
received: 31 01 2023
accepted: 07 03 2023
pubmed: 14 5 2023
medline: 14 5 2023
entrez: 14 5 2023
Statut: epublish

Résumé

Sexual dysfunction is a common consequence for women with spinal cord injury (SCI); however, current treatments are ineffective, especially in the under-prioritized population of women with SCI. This case-series, a secondary analysis of the Epidural Stimulation After Neurologic Damage (E-STAND) clinical trial aimed to investigate the effect of epidural spinal cord stimulation (ESCS) on sexual function and distress in women with SCI. Three females, with chronic, thoracic, sensorimotor complete SCI received daily (24 h/day) tonic ESCS for 13 months. Questionnaires, including the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) were collected monthly. There was a 3.2-point (13.2%) mean increase in total FSFI from baseline (24.5 ± 4.1) to post-intervention (27.8 ± 6.6), with a 4.8-50% improvement in the sub-domains of desire, arousal, orgasm and satisfaction. Sexual distress was reduced by 55%, with a mean decrease of 12 points (55.4%) from baseline (21.7 ± 17.2) to post-intervention (9.7 ± 10.8). There was a clinically meaningful change of 14 points in the International Standards for Neurological Classification of Spinal Cord Injury total sensory score from baseline (102 ± 10.5) to post-intervention (116 ± 17.4), without aggravating dyspareunia. ESCS is a promising treatment for sexual dysfunction and distress in women with severe SCI. Developing therapeutic interventions for sexual function is one of the most meaningful recovery targets for people with SCI. Additional large-scale investigations are needed to understand the long-term safety and feasibility of ESCS as a viable therapy for sexual dysfunction.

Identifiants

pubmed: 37179555
doi: 10.3389/fnins.2023.1155796
pmc: PMC10167769
doi:

Banques de données

ClinicalTrials.gov
['NCT03026816']

Types de publication

Journal Article

Langues

eng

Pagination

1155796

Informations de copyright

Copyright © 2023 Shackleton, Samejima, Miller, Sachdeva, Parr, Samadani, Netoff, Hocaloski, Elliott, Walter, Darrow and Krassioukov.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Claire Shackleton (C)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Physical Medicine and Rehabilitation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Soshi Samejima (S)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Physical Medicine and Rehabilitation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Tiev Miller (T)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Physical Medicine and Rehabilitation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Rahul Sachdeva (R)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Physical Medicine and Rehabilitation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Ann Parr (A)

Department of Neurosurgery, University of Minnesota, Minneapolis, MN, United States.

Uzma Samadani (U)

Department of Bioinformatics and Computational Biology, University of Minnesota, Minneapolis, MN, United States.
Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, United States.

Theoden Netoff (T)

Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN, United States.

Shea Hocaloski (S)

GF Strong Rehabilitation Centre, Vancouver Coastal Health, Vancouver, BC, Canada.

Stacy Elliott (S)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
GF Strong Rehabilitation Centre, Vancouver Coastal Health, Vancouver, BC, Canada.
Department of Psychiatry, Vancouver Coastal Health Authority, Vancouver, BC, Canada.
Department of Urologic Sciences, Vancouver Coastal Health Authority, Vancouver, BC, Canada.

Matthias Walter (M)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.

David Darrow (D)

Department of Neurosurgery, University of Minnesota, Minneapolis, MN, United States.
Hennepin County Medical Center, Minneapolis, MN, United States.

Andrei Krassioukov (A)

International Collaboration on Repair Discoveries, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Physical Medicine and Rehabilitation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
GF Strong Rehabilitation Centre, Vancouver Coastal Health, Vancouver, BC, Canada.

Classifications MeSH